Proposed Therapies for Pantothenate-Kinase-Associated Neurodegeneration
Multiple approaches to therapy have been proposed for the rare inherited neurodegenerative disease associated with mutations in the PANK2 gene, called pantothenate-kinase-associated neurodegeneration (PKAN). Penetration of the blood-brain barrier for treatment of a central nervous system (CNS) disor...
Main Author: | Suzanne Jackowski |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2019-05-01
|
Series: | Journal of Experimental Neuroscience |
Online Access: | https://doi.org/10.1177/1179069519851118 |
Similar Items
-
A therapeutic approach to pantothenate kinase associated neurodegeneration
by: Lalit Kumar Sharma, et al.
Published: (2018-10-01) -
Precision medicine in pantothenate kinase-associated neurodegeneration
by: Mónica Alvarez-Cordoba, et al.
Published: (2019-01-01) -
Retinitis pigmentosa in pantothenate kinase-associated neurodegeneration
by: José Luiz Pedroso, et al.
Published: (2014-10-01) -
Late Onset Atypical Pantothenate-Kinase-Associated Neurodegeneration
by: Natalie Diaz
Published: (2013-01-01) -
Deep Brain Stimulation for Pantothenate Kinase-Associated Neurodegeneration
by: Pedro J. Garcia-Ruiz, et al.
Published: (2015-01-01)